These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1705062)

  • 1. Value of prostate-specific antigen measurements in predicting lymph node involvement in prostatic cancer.
    Arai Y; Yoshiki T; Yamabe H; Yoshida O
    Urol Int; 1990; 45(6):356-60. PubMed ID: 1705062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
    Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF
    Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
    Stamey TA; Kabalin JN; McNeal JE; Johnstone IM; Freiha F; Redwine EA; Yang N
    J Urol; 1989 May; 141(5):1076-83. PubMed ID: 2468795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative prostate-specific antigen in predicting pathologic stage and grade after radical prostatectomy.
    Winter HI; Bretton PR; Herr HW
    Urology; 1991 Sep; 38(3):202-5. PubMed ID: 1716021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer.
    Ferrari AC; Stone NN; Eyler JN; Gao M; Mandeli J; Unger P; Gallagher RE; Stock R
    J Natl Cancer Inst; 1997 Oct; 89(20):1498-504. PubMed ID: 9337346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.
    Polascik TJ; Manyak MJ; Haseman MK; Gurganus RT; Rogers B; Maguire RT; Partin AW
    Cancer; 1999 Apr; 85(7):1586-92. PubMed ID: 10193950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of lymphatic spreading in prostatic cancer by prostate-specific antigen and Gleason's score.
    Wu TT; Chen KK; Huang JK; Lee YH; Chen MT; Chang LS
    Eur Urol; 1994; 26(3):202-6. PubMed ID: 7528661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The staging pelvic lymphadenectomy: implications as an adjunctive procedure for clinically localized prostate cancer.
    Alagiri M; Colton MD; Seidmon EJ; Greenberg RE; Hanno PM
    Br J Urol; 1997 Aug; 80(2):243-6. PubMed ID: 9284196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
    Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
    Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.
    Partin AW; Carter HB; Chan DW; Epstein JI; Oesterling JE; Rock RC; Weber JP; Walsh PC
    J Urol; 1990 Apr; 143(4):747-52. PubMed ID: 1690309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Micrometastasis (< 1 cm) to Pelvic Lymph Nodes in Prostate Cancer: Role of Preoperative MRI.
    Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH
    AJR Am J Roentgenol; 2015 Sep; 205(3):W328-34. PubMed ID: 26295669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting pelvic lymph node involvement in patients with localized prostate cancer.
    Ekman P
    Eur Urol; 1997; 32 Suppl 3():60-4. PubMed ID: 9267787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
    Stock RG; Stone NN; Ianuzzi C; Unger P
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
    Waehre H; Wanderaas EH; Paus E; Fosså SD
    Eur Urol; 1992; 22(1):33-8. PubMed ID: 1385143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
    Weckermann D; Dorn R; Trefz M; Wagner T; Wawroschek F; Harzmann R
    J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Pelvic MRI and Serum Cancer Antigen-125: Selecting Women With Grade 1 Endometrial Cancer for Lymphadenectomy.
    Sadowski EA; Robbins JB; Guite K; Patel-Lippmann K; Munoz del Rio A; Kushner DM; Al-Niaimi A
    AJR Am J Roentgenol; 2015 Nov; 205(5):W556-64. PubMed ID: 26496578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.